Optimising Monoclonal Antibody Therapies for Inflammatory Bowel Diseas

Optimising Monoclonal Antibody Therapies for Inflammatory Bowel Diseas

Introduction

The therapeutic armamentarium for the treatment of inflammatory bowel disease (IBD) has expanded rapidly in recent years, driven by a better understanding of the immunopathology that initiates and perpetuates intestinal…

Continue Reading